Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
deCODE genetics: The rate, nature and transmission of mitochondrial DNA mutations in humans 2024-06-07 23:00
IONETIX Produces First Batch of Actinium-225 2024-06-07 20:27
Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024 2024-06-07 19:00
Clinical Data of First-in-class HBV-specificTCR T Cell Therapy (SCG101) Presented at ESAL Congress Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma 2024-06-07 16:51
MLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's Disease 2024-06-07 15:00
Alphamab Oncology Collaborated with ArriVent in relation to the Research, Development and Commercialization of ADC Products 2024-06-06 10:21
Tianlong Promotes Environmental Sustainability and Hygiene Monitoring with its Biolum Portable ATP Hygiene Monitoring System Series 2024-06-05 14:13
Xinhua Silk Road: Enterprise in E. China's Shandong Weihai dedicated to American ginseng products dev't 2024-06-05 11:16
Zymo Research Unveils PureRec DSN: The Most Selective Duplex-Specific Nuclease 2024-06-04 21:00
Angel Yeast Partners with BakeMark Launching Multiple Product Lines at Bakery China 2024 2024-06-04 19:00
AmpleLogic Launches Advanced aPaaS for Life Sciences with 14 Ready-to-Use Applications 2024-06-04 13:30
RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88 2024-06-04 09:38
Built by Nature Prize Awards €500,000 to Biobased Construction Innovators 2024-06-04 08:00
BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx 2024-06-03 23:37
Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification 2024-06-03 20:00
HistoIndex to Showcase Groundbreaking AI-powered Stain-free Digital Pathology Advances with 8 Accepted Abstracts at EASL Congress 2024 2024-06-03 20:00
Alphamab Oncology Presented Chinese Clinical Data of Anti-HER2 Bispecific ADC JSKN003 for the First Time at the 2024 ASCO Annual Meeting 2024-06-03 10:17
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer and Gastric Cancer 2024-06-03 09:35
Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging 2024-06-03 09:08
Innovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting 2024-06-02 13:19
1 19 20 21 22 23 235